This strategy invests primarily in large cap US equities that pay a dividend. It also deploys a beta weighted hedge on the S&P 500. It is a smart beta dividend strategy that looks to track common dividend benchmarks in its equity portfolio while enhancing the returns thru targeted allocation. The allocations are adjusted based on our core research platform. Our equity portfolio is overweight the dividend stocks that Alpha DNA believes will out-perform Wall Street's expectations for growth in EPS and Revenue. In addition, the portfolio is underweight the stocks it expects to under-perform the Wall street analyst consensus. Alpha DNA uses machine learning and alternative data sources as the under-pinning of its research platform. The portfolio hedges are index options on the S&P 500 and they are inversely correlated to the broad large cap equity markets. The portfolio is actively managed and rebalanced regularly.
All Returns below are reported Net of Fees. You can adjust the time period for the returns but the default time period is since inception.
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | YTD |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 0.95% | 0.46% | 3.14% | -2.56% | 2.20% | -0.52% | 3.28% | 3.31% | -0.19% | -0.85% | 3.88% | - | 13.66% |
2023 | -0.90% | -2.55% | -0.79% | 2.23% | -3.34% | 3.36% | 2.75% | -2.39% | -3.11% | -0.69% | 2.38% | 3.31% | -0.12% |
2022 | - | - | - | - | - | - | - | -1.46% | -3.49% | 7.61% | 3.52% | -2.67% | 3.11% |
Alpha DNA Enhanced Dividend - Hedged | Custom 100% S&P 500 Dividend Aristocrats / 30% Short S&P500 | |
---|---|---|
Cumulative Return: | 17.06% | 11.68% |
1 Year Return: | 17.42% | 11.81% |
Standard Deviation (Annual): | 9.82% | 12.80% |
Downside Deviation (Annual): | 5.24% | 7.87% |
Alpha DNA Enhanced Dividend - Hedged | Custom 100% S&P 500 Dividend Aristocrats / 30% Short S&P500 | |
Sharpe Ratio (Annualized): | 0.24 | 0.05 % |
Sortino (Annualized): | 0.31 | -0.02 |
Alpha DNA Enhanced Dividend - Hedged vs. | Custom 100% S&P 500 Dividend Aristocrats / 30% Short S&P500 |
Beta: | 0.70 |
Alpha: | 0.28 |
R Squared: | 0.83 |
ALPHA DNA Enhanced Dividend - Hedged Composite includes all institutional and retail portfolios that invest in a portfolio of dividend stocks with an index hedge. The portfolio is made up of Large Cap U.S. equities that pay dividends on a recurring basis and also includes a beta weighted hedge indexed to the S&P 500. The strategy aims to perform very similarly to the broad dividend benchmark and achieve modest out- performance by identifying the stocks most likely to out- perform Wall Street’s expectations and over- weighting the portfolio towards those stocks. The portfolio also under- weights any stocks that do Alpha DNA believes are likely to under- perform the Wall Street expectations. Alpha DNA deploys an innovative new research approach; ADNA tracks the digital Internet footprint of publicly traded companies to find hidden demand trends in the marketplace. This composite includes all portfolios that were at least 70% dedicated to this strategy. The benchmark is the custom blend of 100% of the S&P 500 Dividend Aristocrat Index and -30% of the returns of the S&P 500 – assumed it is rebalanced monthly at month end. The S&P500 Dividend Aristocrat Index is a collection of the dividend paying stocks within the S&P 500 that have continually increased their dividend payout over the long term. The S&P500 Index is a collection of 500 of the largest market capitalized publicly traded companies listed on US Exchanges and is maintained by Standard and Poor’s. The composite was created July 1, 2023. The inception date of the strategy is August 1, 2022.